Macrophages and fibroblasts play central roles in coordinating inflammation and tissue repair, whilst dysregulation of macrophage-fibroblast crosstalk drives pathological outcomes such as chronic inflammation and fibrosis. Glycosaminoglycans (GAGs), key components of the extracellular matrix (ECM), interact with cytokines and growth factors that modulate macrophage polarisation and direct fibroblast activity, making them attractive candidates for developing immune-instructive biomaterials. However, the optimal GAG compositions that promote macrophage-mediated repair and fibroblast-driven ECM remodelling remain unclear. Here, we report an unbiased screening of 82 surface-adsorbed GAG combinations to identify candidates capable of modulating macrophage-fibroblast interactions. Leveraging cytokine profiling, surface marker immunostaining, gene expression, principal component analysis (PCA), and hierarchical clustering, we identified ’hit’ GAG combinations that induced distinct, non-canonical macrophage activation programmes characterised by coordinated inflammatory and regulatory signalling, alongside enhanced fibroblast proliferation. Shortlisted formulations were validated using expanded biological replication, orthogonal phenotypic, transcriptional and functional analyses, assessment in macrophage-fibroblast co-culture systems, and in an in vivo diabetic wound model. These data demonstrated that 'hit' GAG formulations modulated macrophage functional activation states, promoted collagen and ECM synthesis, facilitated vascular and lymphatic vessel formation, and accelerated wound closure. Complementary metabolomic profiling using OrbiSIMS and molecular formula prediction (MFP), revealed macrophage metabolic reprogramming as a potential mechanism underlying these pro-healing effects. Collectively, this study established an unbiased methodology for discovering immune-instructive GAGs in supporting pro-healing responses for potential wound-healing applications.Keywords: Glycosaminoglycans; Macrophage-fibroblast crosstalk; Immunomodulation; Diabetic wound healing; Combinatorial screening; OrbiSIMS metabolomics